JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4451
Mission Produce
AVO
$1.12B
| $610K | ﹤0.01% |
60,457
+3,650
| +6% | +$33.9K |
2020 Q4
12 quarters
|
|
4452
Northern Trust Quality Dividend Defensive ETF
QDEF
$547M
| $610K | ﹤0.01% |
+10,328
| New | +$579K |
2023 Q4
0 quarters
|
|
|
TIO
4453
DELISTED
Tingo Group, Inc. Common Stock
TIO
| $610K | ﹤0.01% |
883,494
+47,624
| +6% | +$38.3K |
2023 Q2
2 quarters
|
|
4454
Overlay Shares Short Term Bond ETF
OVT
$59.9M
| $609K | ﹤0.01% |
28,040
+12,219
| +77% | +$259K |
2023 Q3
1 quarter
|
|
4455
PUT
Bilibili
BILI
$5.95B
| $609K | ﹤0.01% |
+50,000
| New | +$653K |
2023 Q4
0 quarters
|
|
4456
Target Hospitality
TH
$1.84B
| $607K | ﹤0.01% |
62,341
-11,979
| -16% | -$148K |
2019 Q1
19 quarters
|
|
|
DHIL
4457
DELISTED
Diamond Hill
DHIL
| $604K | ﹤0.01% |
3,646
+1,327
| +57% | +$215K |
2017 Q4
24 quarters
|
|
4458
Daily Journal
DJCO
$905M
| $603K | ﹤0.01% |
1,770
+857
| +94% | +$268K |
2017 Q4
24 quarters
|
|
4459
iShares MSCI Saudi Arabia ETF
KSA
$585M
| $602K | ﹤0.01% |
14,214
-98,381
| -87% | -$3.86M |
2020 Q3
13 quarters
|
|
|
ITCI
4460
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $602K | ﹤0.01% |
+8,400
| New | +$483K |
2023 Q4
0 quarters
|
|
|
EXAI
4461
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $602K | ﹤0.01% |
93,848
-36,165
| -28% | -$205K |
2023 Q1
3 quarters
|
|
|
INFA
4462
DELISTED
Informatica
INFA
| $602K | ﹤0.01% |
21,188
+365
| +2% | +$8.77K |
2021 Q4
8 quarters
|
|
|
VNET
4463
PUT
VNET Group
VNET
$1.46B
| $600K | ﹤0.01% |
+209,200
| New | +$630K |
2023 Q4
0 quarters
|
|
4464
Anavex Life Sciences
AVXL
$169M
| $600K | ﹤0.01% |
64,436
+352
| +0.5% | +$2.42K |
2019 Q2
18 quarters
|
|
4465
CALL
Cigna
CI
$71.5B
| $599K | ﹤0.01% |
2,000
| – | – |
2021 Q2
10 quarters
|
|
4466
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.18B
| $598K | ﹤0.01% |
22,155
+457
| +2% | +$11.3K |
2021 Q3
9 quarters
|
|
4467
Vivid Seats
SEAT
$39.6M
| $597K | ﹤0.01% |
4,723
+2,862
| +154% | +$392K |
2022 Q2
6 quarters
|
|
4468
BlackRock Science and Technology Trust
BST
$1.78B
| $596K | ﹤0.01% |
17,713
+13,124
| +286% | +$432K |
2020 Q4
12 quarters
|
|
4469
Maplebear
CART
$10.5B
| $596K | ﹤0.01% |
25,377
-369,676
| -94% | -$9.3M |
2023 Q3
1 quarter
|
|
4470
iShares US Industrials ETF
IYJ
$2.02B
| $594K | ﹤0.01% |
5,196
+2,843
| +121% | +$297K |
2015 Q4
32 quarters
|
|
|
CERE
4471
CALL
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $594K | ﹤0.01% |
+14,000
| New | +$402K |
2023 Q4
0 quarters
|
|
4472
ProShares Short 7-10 Year Treasury
TBX
$20.9M
| $592K | ﹤0.01% |
20,701
+257
| +1% | +$7.78K |
2023 Q3
1 quarter
|
|
4473
Park-Ohio Holdings
PKOH
$686M
| $591K | ﹤0.01% |
21,922
+3,253
| +17% | +$76.8K |
2013 Q2
42 quarters
|
|
4474
CALL
Zoom
ZM
$27.1B
| $590K | ﹤0.01% |
8,200
| – | – |
2023 Q3
1 quarter
|
|
|
ILPT
4475
Industrial Logistics Properties Trust
ILPT
$473M
| $589K | ﹤0.01% |
125,235
+121,611
| +3,356% | +$394K |
2018 Q1
23 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.